Supply Security
Ensuring the rapid supply of vaccine adjuvants is critical in addressing public health emergencies. Swift availability of adjuvants is essential during outbreaks to accelerate vaccine production and distribution, mitigating the spread of infectious diseases.
Moreover, timely and affordable access to adjuvants supports the development and deployment of new vaccines, crucial in combating emerging pathogens and preventing future pandemics. Efficient supply chains and strategic stockpiling of adjuvants are therefore indispensable for global health security.
Affordable cost for global health programs
Q-VANT philosophy of public health considers the supply of adjuvant to both massive public health immunization with robust and affordable adjuvants as well answering the requirements for prevention and therapy against specialized diseases.
Supply risk of Tree Bark saponin
As of 2024, numerous saponin materials commercially available, included in marketed vaccines and for new vaccine developments, are still reliant on the limited and unsecure quillaja tree bark supply, thus may pose a supply issue to the world health system, as exposed.
